Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus.

Puhong ZhangHeng ZhangXian LiMinyuan ChenDu WangLi-Nong Ji

Published in: Endocrinology, diabetes & metabolism (2020)

Among patients with T2DM who initiated BI therapy due to uncontrolled hyperglycaemia by OADs, the proportion of insulin discontinuation was high within 6 months. Further study is needed to understand the reason behind the BI discontinuation.

Keyphrases

type diabetes
glycemic control
metabolic syndrome
bone marrow
weight loss
replacement therapy